|
Volumn 19, Issue 17-19, 2001, Pages 2716-2721
|
The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines
|
Author keywords
Influenza; PER.C6; Vaccine
|
Indexed keywords
INFLUENZA VACCINE;
ANTIGENICITY;
CELL CULTURE;
CELL STRAIN;
CONCENTRATION RESPONSE;
CONFERENCE PAPER;
CONTROLLED STUDY;
HUMAN;
HUMAN CELL;
IMMUNOGENICITY;
INFLUENZA VIRUS A;
INFLUENZA VIRUS B;
LIFE CYCLE;
NONHUMAN;
PRIORITY JOURNAL;
VACCINE PRODUCTION;
VIROGENESIS;
VIRUS INFECTIVITY;
VIRUS REPLICATION;
ZYGOTE;
ANIMALS;
ANTIGENS, VIRAL;
BIOREACTORS;
CELL LINE;
CHICKENS;
EDETIC ACID;
HEMAGGLUTININS, VIRAL;
HUMANS;
INFLUENZA VACCINES;
ORTHOMYXOVIRIDAE;
TRYPSIN;
VIRUS CULTIVATION;
VIRUS REPLICATION;
|
EID: 0035925715
PISSN: 0264410X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0264-410X(00)00508-9 Document Type: Conference Paper |
Times cited : (165)
|
References (9)
|